BPL 003
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley dealEli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental...
Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: ReportEli Lilly is reportedly negotiating to acquire psychedelic drugmaker AtaiBeckley. AtaiBeckley shares experienced a significant surge follow...
Market Now: 52 stocks hit fresh 52 week low in early tradeIn the BSE 500 index, 240 stocks were trading in green, while 251 numbers of stocks remained in the grip of bears.
Stock market update: BSE Smallcap trades flat; Jet Airways among top losersEquity markets were in the higher territory on gains in IT, pharma, telecom, bank and financial stocks.
Sensex, Nifty snap record 8-day winning streak on profit-takingProfit taking in heavyweights Infosys, RIL, ICICI Bank and ITC also weighed on the equities.
Load More